Augmented and standard Berlin-Frankfurt-Münster chemotherapy for treatment of adult acute lymphoblastic leukemia

The augmented Berlin-Frankfurt-Münster (aBFM) regimen has demonstrated improved outcomes in children with acute lymphomblastic leukemia (ALL), but efficacy in adults is unknown. In this retrospective study, we evaluated clinical outcomes in 29 adult ALL patients (ages 19–70) treated with standard BF...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Chang, Julie E., Medlin, Stephen C., Kahl, Brad S., Longo, Walter L., Williams, Eliot C., Lionberger, Jack, Kim, KyungMann, Kim, Jihoon, Esterberg, Elizabeth, Juckett, Mark B.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2008
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2844086/
https://ncbi.nlm.nih.gov/pubmed/19052977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428190802517732
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky